PharmaCyte Biotech, Inc. Quarterly Current Ratio in % from Q4 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
PharmaCyte Biotech, Inc. quarterly Current Ratio history and growth rate from Q4 2011 to Q2 2024.
  • PharmaCyte Biotech, Inc. Current Ratio for the quarter ending July 31, 2024 was 790 %, a 88.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 790 -6.11K -88.6% Jul 31, 2024
Q1 2024 1.2K -6.68K -84.8% Apr 30, 2024
Q4 2023 1.87K -6.21K -76.9% Jan 31, 2024
Q3 2023 3.54K -5.38K -60.3% Oct 31, 2023
Q2 2023 6.9K -6.28K -47.6% Jul 31, 2023
Q1 2023 7.88K -2.87K -26.7% Apr 30, 2023
Q4 2022 8.08K +821 +11.3% Jan 31, 2023
Q3 2022 8.92K +5.12K +135% Oct 31, 2022
Q2 2022 13.2K +12.8K +3504% Jul 31, 2022
Q1 2022 10.7K +10.4K +2849% Apr 30, 2022
Q4 2021 7.26K +6.96K +2348% Jan 31, 2022
Q3 2021 3.8K +3.61K +1886% Oct 31, 2021
Q2 2021 366 +272 +290% Jul 31, 2021
Q1 2021 364 +309 +552% Apr 30, 2021
Q4 2020 297 +248 +507% Jan 31, 2021
Q3 2020 191 +113 +145% Oct 31, 2020
Q2 2020 93.8 -18 -16.1% Jul 31, 2020
Q1 2020 55.9 -98.2 -63.7% Apr 30, 2020
Q4 2019 48.8 -135 -73.4% Jan 31, 2020
Q3 2019 78 -110 -58.4% Oct 31, 2019
Q2 2019 112 -144 -56.3% Jul 31, 2019
Q1 2019 154 -185 -54.6% Apr 30, 2019
Q4 2018 183 -241 -56.8% Jan 31, 2019
Q3 2018 188 -322 -63.2% Oct 31, 2018
Q2 2018 256 -231 -47.4% Jul 31, 2018
Q1 2018 339 -146 -30.1% Apr 30, 2018
Q4 2017 425 +23.4 +5.83% Jan 31, 2018
Q3 2017 510 +169 +49.4% Oct 31, 2017
Q2 2017 486 +173 +55.2% Jul 31, 2017
Q1 2017 486 +191 +64.8% Apr 30, 2017
Q4 2016 401 +116 +40.8% Jan 31, 2017
Q3 2016 341 +54.2 +18.9% Oct 31, 2016
Q2 2016 313 +4.06 +1.31% Jul 31, 2016
Q1 2016 295 -78.9 -21.1% Apr 30, 2016
Q4 2015 285 -396 -58.1% Jan 31, 2016
Q3 2015 287 -384 -57.2% Oct 31, 2015
Q2 2015 309 -109 -26.1% Jul 31, 2015
Q1 2015 374 +91.5 +32.4% Apr 30, 2015
Q4 2014 681 +590 +652% Jan 31, 2015
Q3 2014 671 +612 +1036% Oct 31, 2014
Q2 2014 418 +365 +683% Jul 31, 2014
Q1 2014 282 +243 +631% Apr 30, 2014
Q4 2013 90.5 +57.1 +171% Jan 31, 2014
Q3 2013 59.1 +29.6 +100% Oct 31, 2013
Q2 2013 53.5 +28.7 +116% Jul 31, 2013
Q1 2013 38.6 +18.1 +88.4% Apr 30, 2013
Q4 2012 33.3 +19.3 +137% Jan 31, 2013
Q3 2012 29.5 Oct 31, 2012
Q2 2012 24.8 Jul 31, 2012
Q1 2012 20.5 Apr 30, 2012
Q4 2011 14.1 Jan 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.